Use of IPO proceeds for R&D and investment in human resources
First written in FY2018. 3 of 6 entries say "Restated". Latest entry: FY2020.
1 other company's latest entry also says "Dropped".
- FY2020DroppedAnnual reportThis annual securities report contains no explicit reference to a plan to allocate listing proceeds to research and development expenses, recruitment expenses, or other purposes.
- FY2019RestatedAnnual report
「The intended uses of proceeds from the public offering at the time of listing are research and development expenses for improving the existing speech synthesis engine, developing next-generation speech synthesis technology, and developing speech synthesis engines for multiple languages, as well as recruitment expenses and personnel costs to secure talented human resources for future business expansion.」
Restates the plan to allocate listing proceeds to research and development, multilingual engines, and securing human resources. The company raised ¥257.475 million through financing activities, including share issuance, but does not specify a direct correspondence with actual individual uses of funds. - FY2019-Q3RestatedAnnual report
「In addition, the company issued 85,000 new common shares through a private placement conducted in connection with the offering of the company's shares by way of over-allotment, with a payment date of 27 July 2018. As a result, share capital increased by ¥39.100 million and capital surplus increased by ¥39.100 million.」
Restates the execution and amount of funds raised through the public offering and private placement associated with the listing. This filing also does not specify actual allocations to research and development expenses or recruitment expenses. - FY2019-Q2AdvancedAnnual report
「This was due to a ¥291.114 million increase in cash and deposits resulting from the issuance of new shares through a public offering, a private placement, and the disposal of treasury shares, among other transactions.」
In addition to the public offering at the time of listing, funds were raised through a private placement and the disposal of treasury shares, and the proceeds were disclosed as an increase in cash and deposits. This filing does not specify actual allocations to research and development expenses or recruitment expenses. - FY2019-Q1RestatedAnnual report
「Use of funds: The funds are scheduled to be allocated to research and development expenses and recruitment expenses.」
The company continues to plan to allocate proceeds from the private placement associated with the over-allotment to research and development expenses and recruitment expenses. - FY2018First statedAnnual report
「The funds are scheduled to be allocated to research and development expenses and recruitment expenses.」
The stated uses of funds are improving the existing engine, next-generation technologies, engines for multiple languages, and securing human resources.